AMI Asset Management Corp Has $27.74 Million Stake in Synopsys, Inc. $SNPS

AMI Asset Management Corp reduced its position in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 3.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 56,230 shares of the semiconductor company’s stock after selling 1,882 shares during the quarter. Synopsys accounts for 1.5% of AMI Asset Management Corp’s investment portfolio, making the stock its 28th biggest holding. AMI Asset Management Corp’s holdings in Synopsys were worth $27,743,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Lionshead Wealth Management LLC raised its position in Synopsys by 1.9% during the second quarter. Lionshead Wealth Management LLC now owns 914 shares of the semiconductor company’s stock valued at $469,000 after buying an additional 17 shares during the period. YANKCOM Partnership grew its stake in Synopsys by 3.3% during the 2nd quarter. YANKCOM Partnership now owns 537 shares of the semiconductor company’s stock valued at $275,000 after acquiring an additional 17 shares in the last quarter. Manchester Capital Management LLC increased its holdings in shares of Synopsys by 5.3% in the 2nd quarter. Manchester Capital Management LLC now owns 340 shares of the semiconductor company’s stock valued at $174,000 after purchasing an additional 17 shares during the period. Hemington Wealth Management increased its holdings in shares of Synopsys by 10.1% in the 2nd quarter. Hemington Wealth Management now owns 197 shares of the semiconductor company’s stock valued at $100,000 after purchasing an additional 18 shares during the period. Finally, Concord Asset Management LLC VA lifted its position in shares of Synopsys by 0.8% in the second quarter. Concord Asset Management LLC VA now owns 2,379 shares of the semiconductor company’s stock worth $1,220,000 after purchasing an additional 18 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys Price Performance

NASDAQ SNPS opened at $475.50 on Friday. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The company has a fifty day simple moving average of $436.99 and a 200 day simple moving average of $503.73. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. The company has a market cap of $90.97 billion, a P/E ratio of 59.51, a P/E/G ratio of 3.96 and a beta of 1.16.

Synopsys (NASDAQ:SNPSGet Free Report) last released its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same quarter in the previous year, the business earned $3.40 EPS. The business’s revenue was up 37.8% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, sell-side analysts predict that Synopsys, Inc. will post 10.64 EPS for the current year.

Insider Activity at Synopsys

In related news, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares in the company, valued at $8,221,058.34. This represents a 17.01% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.62% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on SNPS shares. Needham & Company LLC boosted their price objective on shares of Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. Citigroup started coverage on shares of Synopsys in a research note on Monday, November 24th. They issued a “buy” rating and a $580.00 price target on the stock. Stifel Nicolaus cut their price objective on Synopsys from $650.00 to $550.00 and set a “buy” rating for the company in a report on Wednesday, September 10th. JPMorgan Chase & Co. boosted their target price on Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a research note on Thursday, December 11th. Finally, Wells Fargo & Company upped their target price on Synopsys from $445.00 to $500.00 and gave the stock an “equal weight” rating in a research report on Thursday, December 11th. Eleven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $562.13.

Read Our Latest Analysis on SNPS

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.